These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24942209)

  • 1. Dual-modal MRI contrast agent with aggregation-induced emission characteristic for liver specific imaging with long circulation lifetime.
    Chen Y; Li M; Hong Y; Lam JW; Zheng Q; Tang BZ
    ACS Appl Mater Interfaces; 2014 Jul; 6(13):10783-91. PubMed ID: 24942209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gd complexes of diethylenetriaminepentaacetic acid conjugates of low-molecular-weight chitosan oligosaccharide as a new liver-specific MRI contrast agent.
    Huang Y; Cao B; Yang X; Zhang Q; Han X; Guo Z
    Magn Reson Imaging; 2013 May; 31(4):604-9. PubMed ID: 23102519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
    Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
    Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a diagnostic polymersome system for potential imaging delivery.
    Huang WC; Chen YC; Hsu YH; Hsieh WY; Chiu HC
    Colloids Surf B Biointerfaces; 2015 Apr; 128():67-76. PubMed ID: 25731095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulating the surface coating of ultra-small Gd2O3 nanoparticles for improved T1-weighted MR imaging.
    Fang J; Chandrasekharan P; Liu XL; Yang Y; Lv YB; Yang CT; Ding J
    Biomaterials; 2014 Feb; 35(5):1636-42. PubMed ID: 24290697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic multiarm star block copolymer-based multifunctional unimolecular micelles for cancer targeted drug delivery and MR imaging.
    Li X; Qian Y; Liu T; Hu X; Zhang G; You Y; Liu S
    Biomaterials; 2011 Sep; 32(27):6595-605. PubMed ID: 21663960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium containing photochromic micelles as potential magnetic resonance imaging traceable drug carriers.
    Heta Y; Kumaki K; Hifumi H; Citterio D; Tanimoto A; Suzuki K
    Photochem Photobiol; 2012; 88(4):876-83. PubMed ID: 22364381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic Nanoaggregates with Bimodal MRI and Optical Properties Exhibiting Magnetic Field Dependent Switching from Positive to Negative Contrast Enhancement.
    Harris M; Laskaratou D; Elst LV; Mizuno H; Parac-Vogt TN
    ACS Appl Mater Interfaces; 2019 Feb; 11(6):5752-5761. PubMed ID: 30640430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a Thermal-Responsive Dual-Modal Supramolecular Probe for Magnetic Resonance Imaging and Fluorescence Imaging.
    Zhou M; Li L; Xie W; He Z; Li J
    Macromol Rapid Commun; 2021 Aug; 42(16):e2100248. PubMed ID: 34272782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles.
    Xiao N; Gu W; Wang H; Deng Y; Shi X; Ye L
    J Colloid Interface Sci; 2014 Mar; 417():159-65. PubMed ID: 24407672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-responsive nanoparticles with Aggregation-Induced Emission (AIE) characteristic for fluorescence imaging.
    Cheng W; Wang G; Pan X; Zhang Y; Tang BZ; Liu Y
    Macromol Biosci; 2014 Aug; 14(8):1059-66. PubMed ID: 24771703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Enhancement of Fluorescence and Magnetic Resonance Signals Assisted by Albumin Aggregate for Dual-Modal Imaging.
    Wang L; Wan Q; Zhang R; Situ B; Ni K; Gao J; Feng X; Zhang P; Wang Z; Qin A; Tang BZ
    ACS Nano; 2021 Jun; 15(6):9924-9934. PubMed ID: 34096697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
    Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraphenylethylene-conjugated polycation covered iron oxide nanoparticles for magnetic resonance/optical dual-mode imaging.
    Yang L; Fu S; Liu L; Cai Z; Xia C; Song B; Gong Q; Lu Z; Ai H
    Regen Biomater; 2021 Jun; 8(3):rbab023. PubMed ID: 34211733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gadolinium complexes with polyoxometalates as potential MRI contrast agents.
    Li Z; Li W; Li X; Pei F; Li Y; Lei H
    Magn Reson Imaging; 2007 Apr; 25(3):412-7. PubMed ID: 17371733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
    Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.